Диссертация (1145849), страница 21
Текст из файла (страница 21)
//Цитология. – 1968. – Т. 5.– №. 557. – С. 67.16. Хайдуков С.В., Зурочка А.В. Тотолян А.А., Черешнев В.А. Основные ималые популяции лимфоцитов периферической крови человека и ихнормативные значения (методом многоцветного цитометрическогоанализа) //Медицинская иммунология. – 2009. – Т. 11. – №. 2-3. – С. 227238.17. Abreu S.C., Antunes M.A., de Castro J.C., de Oliveira M.V., BandeiraE., Ornellas D.S., Diaz B.L., Morales M.M., Xisto D.G., Rocco P.R.
Bonemarrow-derived mononuclear cells vs. mesenchymal stromal cells inexperimental allergic asthma //Respiratory physiology & neurobiology. – 2013.– V. 187. – №. 2. – P. 190-198.18. Airas L., Niemelä J., Salmi M., Puurunen T., Smith D.J., Jalkanen S.Differential regulation and function of CD73, a glycosyl-phosphatidylinositol–130linked 70-kD adhesion molecule, on lymphocytes and endothelial cells //TheJournal of cell biology. – 1997. – V.
136. – №. 2. – P. 421-431.19. Akira S., Isshili H., Nakajima T., Kinoshite S., Nishio Y., Natsuka S.,Kishimoto T. Regulation of Expression of the Interleukin 6 Gene: Structure andFunction of the Transcription Factor NF-IL6 //Ciba Foundation Symposium167-Polyfunctional Cytokines: IL-6 and LIF. – John Wiley & Sons, Ltd., 1992.– С. 47-67.20. Akdis M., Blaser K., Akdis C. A. T regulatory cells in allergy: novel concepts inthe pathogenesis, prevention, and treatment of allergic diseases //Journal ofallergy and clinical immunology. – 2005.
– Т. 116. – №. 5. – С. 961-968.21. Akira S., Takeda K. Toll-like receptor signalling //Nature reviews immunology.– 2004. – Т. 4. – №. 7. – С. 499-51122. Alkim C., Balci M., Alkim H., Dağli U., Parlak E., Tezel A., Ulker A. Theimportance of peripheral immune cells in inflammatory bowel disease //Turk JGastroenterol. – 2007. – V. 18. – №. 2. – P. 82-88.23. Amé-Thomas P., Hajjami H.M.-E., Monvoisin C., Jean R., Monnier D., CauletMaugendre S., Guillaudeux T., Lamy T., Fest T., Tarte K. Human mesenchymalstem cells isolated from bone marrow and lymphoid organs support tumor B-cellgrowth: role of stromal cells in follicular lymphoma pathogenesis //Blood.
–2007. – V. 109. – №. 2. – P. 693-702.24. Anderson P., Carrillo-Gálvez A.B., García-Pérez A., Cobo M., Martín F. CD105(endoglin)-negative murine mesenchymal stromal cells define a new multipotentsubpopulation with distinct differentiation and immunomodulatory capacities//PloS one. – 2013. – V. 8. – №. 10. – P. e76979.25. Antúnez C., Torres M.J., Mayorga C., Corzo J.L., Jurado A., Santamaría-BabiL.F., Vera A., Blanca M. Cytokine production, activation marker, and skinhoming receptor in children with atopic dermatitis and bronchial asthma//Pediatric allergy and immunology. – 2006.
– V. 17. – №. 3. – P. 166-174.26. Araki H., Yoshinaga K., Boccuni P., Zhao Y., Hoffman R., Mahmud N.Chromatin-modifying agents permit human hematopoietic stem cells to undergomultiple cell divisions while retaining their repopulating potential //Blood. –2007. – V. 109. – №. 8. – P. 3570-3578.27. Aruffo A., Stamenkovic I., Melnick M., Underhill C.B., Seed B. CD44 is theprincipal cell surface receptor for hyaluronate //Cell.
– 1990. – V. 61. – №. 7. –P. 1303-1313.13128. Arthur A., Zannettino A., Gronthos S. The therapeutic applications ofmultipotential mesenchymal/stromal stem cells in skeletal tissue repair //Journalof cellular physiology. – 2009. – V. 218. – №. 2. – P. 237-245.29.
Asari S., Itakura S., Ferreri K., Liu C.P., Kuroda Y., Kandeel F., Mullen Y.Mesenchymal stem cells suppress B-cell terminal differentiation //Experimentalhematology. – 2009. – V. 37. – №. 5. – P. 604-615.30. Asea A., Rehli M., Kabingu E., Boch J.A., Bare O., Auron P.E., StevensonM.A., Calderwood S.K. Novel signal transduction pathway utilized byextracellular HSP70 role of Toll-like receptor (TLR) 2 and TLR4 //Journal ofBiological Chemistry. – 2002. – V.
277. – №. 17. – P. 15028-15034.31. Aslan H., Zilberman Y., Kandel L., Liebergall M., Oskouian R.J., Gazit D.,Gazit Z. Osteogenic Differentiation of Noncultured Immunoisolated BoneMarrow-Derived CD105+ Cells //Stem Cells. – 2006. – V. 24. – №. 7. – P.1728-1737.32. Aust L., Devlin B., Foster S.J., Halvorsen Y.D., Hicok K., du Laney T., SenA., Willingmyre G.D., Gimble J.M. Yield of human adipose-derived adult stemcells from liposuction aspirates //Cytotherapy. – 2004. – V. 6. – №.
1. – P. 7-14.33. Bai L., Lennon D.P., Eaton V., Maier K., Caplan A.I., Miller S.D., Miller R.H.Human bone marrow‐ derived mesenchymal stem cells induce Th2‐ polarizedimmune response and promote endogenous repair in animal models of multiplesclerosis //Glia. – 2009. – V. 57. – №. 11. – P. 1192-1203.34. Baksh D., Yao R., Tuan R.S. Comparison of proliferative and multilineagedifferentiation potential of human mesenchymal stem cells derived fromumbilical cord and bone marrow //Stem cells.
– 2007. – V. 25. – №. 6. – P.1384-1392.35. Basak S., Hoffmann A. Crosstalk via the NF-κB signaling system //Cytokine &growth factor reviews. – 2008. – V. 19. – №. 3. – P. 187-197.36. Bartholomew A., Sturgeon C., Siatskas M., Ferrer K., McIntosh K., Patil S.,Hardy W., Devine S., Ucker D., Deans R., Moseley A., Hoffman R.Mesenchymal stem cells suppress lymphocyte proliferation in vitroand prolongskin graft survival in vivo. //Experimental hematology.
– 2002. – V. 30. – №. 1.– P. 42-48.37. Basciano L., Nemos C., Foliguet B., de Isla N., de Carvalho M., Tran N.,Dalloul A. Long term culture of mesenchymal stem cells in hypoxia promotes agenetic program maintaining their undifferentiated and multipotent status//BMC cell biology. – 2011. – V. 12.
– №. 1. – P. 12.13238. Batten P., Sarathchandra P., Antoniw J.W., Tay S.S., Lowdell M.W., TaylorP.M., Yacoub M.H. Human mesenchymal stem cells induce T cell anergy anddownregulate T cell allo-responses via the TH2 pathway: relevance to tissueengineering human heart valves. //Tissue engineering. – 2006. – V. 12. – №. 8.
–P. 2263-2273.39. Baudin B., Bruneel A., Bosselut N., Vaubourdolle M. A protocol for isolationand culture of human umbilical vein endothelial cells //Nature protocols. – 2007.– V. 2. – №. 3. – P. 481-485.40. Ben-Ami E., Berrih-Aknin S., Miller A.
Mesenchymal stem cells as animmunomodulatory therapeutic strategy for autoimmune diseases//Autoimmunity reviews. – 2011. – V. 10. – №. 7. – P. 410-415.41. Béné M.C. Immunophenotyping of acute leukaemias //Immunology letters. –2005. – V. 98.
– №. 1. – P. 9-21.42. van den Berk L.C., Jansen B.J., Siebers-Vermeulen K.G., Roelofs H., FigdorC.G., Adema G.J., Torensma R. Mesenchymal stem cells respond to TNF but donot produce TNF //Journal of leukocyte biology. – 2010. – V. 87. – №. 2. – P.283-289.43. Bernabeu C., Conley B.A., Vary C.P.H. Novel biochemical pathways ofendoglin in vascular cell physiology //Journal of cellular biochemistry. – 2007.
–V. 102. – №. 6. – P. 1375-1388.44. Bestard O., Cruzado J.M., Mestre M., Caldés A., Bas J., Carrera M., TorrasJ., Rama I., Moreso F., Serón D., Grinyó J.M. Achieving donor-specifichyporesponsiveness is associated with FOXP3+ regulatory T cell recruitment inhuman renal allograft infiltrates //The Journal of Immunology. – 2007. – V.
179.– №. 7. – P. 4901-4909.45. Bhagwat S.V., Lahdenranta J., Giordano R., Arap W., Pasqualini R., ShapiroL.H. CD13/APN is activated by angiogenic signals and is essential for capillarytube formation //Blood. – 2001. – V. 97. – №. 3. – P. 652-659.46. Bianco P., Gehron R.P. Marrow stromal stem cells //J.Clin.Invest. – 2000. –V.105. – P. 1663-1668.47. Bielby R., Jones E., McGonagle D. The role of mesenchymal stem cells inmaintenance and repair of bone //Injury. – 2007. – V. 38. – №. 1.
– P. S26-S32.48. Bocelli-Tyndall C., Bracci L., Spagnoli G., Braccini A., Bouchenaki M.,Ceredig R., Pistoia V., Martin I., Tyndall A. Bone marrow mesenchymalstromal cells (BM-MSCs) from healthy donors and auto-immune diseasepatients reduce the proliferation of autologous-and allogeneic-stimulatedlymphocytes in vitro //Rheumatology. – 2007. – V. 46. – №. 3.
– P. 403-408.13349. Boumaza I., Srinivasan S., Witt W.T., Feghali-Bostwick C., Dai Y., GarciaOcana A., Feili-Hariri M. Autologous bone marrow-derived rat mesenchymalstem cells promote PDX-1 and insulin expression in the islets, alter T cellcytokine pattern and preserve regulatory T cells in the periphery and inducesustained normoglycemia //Journal of autoimmunity.
– 2009. – V. 32. – №. 1. –P. 33-42.50. Braga M., Quecchia C., Cavallucci E., Di Giampaolo L., Schiavone C., PetrarcaC., Di Gioacchino M. T regulatory cells in allergy //International journal ofimmunopathology and pharmacology. – 2010. – V. 24. – №. 1 Suppl. – P. 55S64S.51. Braunstein J., Qiao L, Autschbach F, Schürmann G, Meuer S.. T cells of thehuman intestinal lamina propria are high producers of interleukin-10 //Gut. –1997. – V.
41. – №. 2. – P. 215-220.52. Burr S.P., Dazzi F., Garden O.A. Mesenchymal stromal cells and regulatory Tcells: the Yin and Yang of peripheral tolerance&quest //Immunology and cellbiology. – 2013. – V. 91. – №. 1. – P. 12-18.53. Campioni D., Rizzo R., Stignani M., Melchiorri L., Ferrari L., Moretti S., RussoA., Bagnara G.P., Bonsi L., Alviano F., Lanzoni G., Cuneo A., BaricordiO.R., Lanza F. A decreased positivity for CD90 on human mesenchymal stromalcells (MSCs) is associated with a loss of immunosuppressive activity by MSCs//Cytometry Part B: Clinical Cytometry. – 2009.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
